Key Takeaway
Umbrella review of 11 meta-analyses confirms intermittent fasting effectively reduces body weight, BMI, and fat mass, with moderate certainty evidence for metabolic improvements.
Summary
This umbrella review synthesized evidence from 11 systematic reviews and meta-analyses of randomized controlled trials examining intermittent fasting's effects on health outcomes. The authors used GRADE methodology to assess evidence quality and provide definitive conclusions about IF's efficacy.
The review found convincing or highly suggestive evidence that intermittent fasting reduces body weight, BMI, and fat mass compared to ad libitum eating or continuous energy restriction. Effects on cardiometabolic markers were more variable - blood pressure, fasting insulin, and insulin resistance showed improvements with moderate certainty, while effects on lipids and HbA1c were less consistent.
Importantly, the review found that IF was generally equivalent to continuous caloric restriction for weight loss, suggesting the benefits come from overall energy reduction rather than fasting-specific mechanisms. However, some individuals find IF more sustainable than daily calorie counting, which may improve long-term adherence.
Methods
- Umbrella review methodology following PRISMA guidelines
- Searched PubMed, Embase, Cochrane Library through 2023
- Included systematic reviews and meta-analyses of RCTs only
- Assessed evidence quality using GRADE criteria
- Evaluated outcomes: body composition, metabolic markers, cardiovascular health
- Applied criteria for convincing, highly suggestive, suggestive, or weak evidence
Key Results
- Body weight: Convincing evidence for reduction vs. ad libitum eating (MD: -2.1 to -4.3 kg)
- BMI: Highly suggestive evidence for reduction (MD: -0.6 to -1.5 kg/m²)
- Fat mass: Highly suggestive evidence for reduction
- Blood pressure: Moderate certainty for systolic and diastolic reductions
- Fasting insulin: Moderate certainty for reduction
- HOMA-IR: Moderate certainty for improvement in insulin resistance
- Lipids: Inconsistent effects across reviews; some showed LDL reduction, others no effect
- HbA1c: Low to moderate certainty for modest improvement in diabetic populations
- IF vs. caloric restriction: Generally equivalent outcomes for weight loss
Limitations
- Umbrella review inherits limitations of included meta-analyses
- Heterogeneity in IF protocols (16:8, 5:2, alternate day fasting)
- Most studies were 12 weeks or shorter duration
- Limited data on fasts longer than 24 hours
- Population heterogeneity (healthy, obese, diabetic)
- Publication bias possible in underlying meta-analyses
- Cannot determine optimal IF protocol from available evidence
- Few studies examined autophagy or longevity-related outcomes